logo
Breadcrumbs Image

Pharmacogenomics PGx Market

Pharmacogenomics PGx Market

Global Pharmacogenomics (PGx) Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027


Date: May-2021 | Id: MACRC-71194 | Geographical Scope: Global | Publisher: Mnemonics Research

The global Pharmacogenomics (PGx) market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report.
 The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
 
 By Market Verdors:
 Abbott Laboratories
 Myriad Genetics, Inc.
 Astrazeneca
 Affymetrix, Inc.
 Laboratory Corporation of America Holdings
 Assurex Health, Inc
 Pfizer, Inc
 Illumina, Inc.
 GeneDX
 Pathway Genomics
 Transgenomic, Inc.
 Qiagen, Inc.
 Thermo Fisher Scientific
 Rocheg
 Teva Pharmaceutical Industries Ltd.
 
 By Types:
 Polymerase Chain Reaction (PCR)
 Microarray
 Sequencing
 Other
 
 By Applications:
 Cardiovascular Diseases (CVD)
 Central Nervous System (CNS)
 Cancer/Oncology
 Infectious Diseases
 Other
 
 Key Indicators Analysed
 Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
 Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
 Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
 Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
 Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
 
 Key Reasons to Purchase
 To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
 Assess the production processes, major issues, and solutions to mitigate the development risk.
 To understand the most affecting driving and restraining forces in the market and its impact in the global market.
 Learn about the market strategies that are being adopted by leading respective organizations.
 To understand the future outlook and prospects for the market.
 Besides the standard structure reports, we also provide custom research according to specific requirements.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
1 Report Overview
 1.1 Study Scope and Definition
 1.2 Research Methodology
 1.2.1 Methodology/Research Approach
 1.2.2 Data Source
 1.3 Key Market Segments
 1.4 Players Covered: Ranking by Pharmacogenomics (PGx) Revenue
 1.5 Market Analysis by Type
 1.5.1 Global Pharmacogenomics (PGx) Market Size Growth Rate by Type: 2021 VS 2027
 1.5.2 Polymerase Chain Reaction (PCR)
 1.5.3 Microarray
 1.5.4 Sequencing
 1.5.5 Other
 1.6 Market by Application
 1.6.1 Global Pharmacogenomics (PGx) Market Share by Application: 2022-2027
 1.6.2 Cardiovascular Diseases (CVD)
 1.6.3 Central Nervous System (CNS)
 1.6.4 Cancer/Oncology
 1.6.5 Infectious Diseases
 1.6.6 Other
 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
 1.7.2 Covid-19 Impact: Commodity Prices Indices
 1.7.3 Covid-19 Impact: Global Major Government Policy
 1.8 Study Objectives
 1.9 Years Considered
 2 Global Pharmacogenomics (PGx) Market Trends and Growth Strategy
 2.1 Market Top Trends
 2.2 Market Drivers
 2.3 Market Challenges
 2.4 Porter’s Five Forces Analysis
 2.5 Market Growth Strategy
 2.6 SWOT Analysis
 3 Global Pharmacogenomics (PGx) Market Players Profiles
 3.1 Abbott Laboratories
 3.1.1 Abbott Laboratories Company Profile
 3.1.2 Abbott Laboratories Pharmacogenomics (PGx) Product Specification
 3.1.3 Abbott Laboratories Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.2 Myriad Genetics, Inc.
 3.2.1 Myriad Genetics, Inc. Company Profile
 3.2.2 Myriad Genetics, Inc. Pharmacogenomics (PGx) Product Specification
 3.2.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.3 Astrazeneca
 3.3.1 Astrazeneca Company Profile
 3.3.2 Astrazeneca Pharmacogenomics (PGx) Product Specification
 3.3.3 Astrazeneca Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.4 Affymetrix, Inc.
 3.4.1 Affymetrix, Inc. Company Profile
 3.4.2 Affymetrix, Inc. Pharmacogenomics (PGx) Product Specification
 3.4.3 Affymetrix, Inc. Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.5 Laboratory Corporation of America Holdings
 3.5.1 Laboratory Corporation of America Holdings Company Profile
 3.5.2 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product Specification
 3.5.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.6 Assurex Health, Inc
 3.6.1 Assurex Health, Inc Company Profile
 3.6.2 Assurex Health, Inc Pharmacogenomics (PGx) Product Specification
 3.6.3 Assurex Health, Inc Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.7 Pfizer, Inc
 3.7.1 Pfizer, Inc Company Profile
 3.7.2 Pfizer, Inc Pharmacogenomics (PGx) Product Specification
 3.7.3 Pfizer, Inc Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.8 Illumina, Inc.
 3.8.1 Illumina, Inc. Company Profile
 3.8.2 Illumina, Inc. Pharmacogenomics (PGx) Product Specification
 3.8.3 Illumina, Inc. Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.9 GeneDX
 3.9.1 GeneDX Company Profile
 3.9.2 GeneDX Pharmacogenomics (PGx) Product Specification
 3.9.3 GeneDX Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.10 Pathway Genomics
 3.10.1 Pathway Genomics Company Profile
 3.10.2 Pathway Genomics Pharmacogenomics (PGx) Product Specification
 3.10.3 Pathway Genomics Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.11 Transgenomic, Inc.
 3.11.1 Transgenomic, Inc. Company Profile
 3.11.2 Transgenomic, Inc. Pharmacogenomics (PGx) Product Specification
 3.11.3 Transgenomic, Inc. Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.12 Qiagen, Inc.
 3.12.1 Qiagen, Inc. Company Profile
 3.12.2 Qiagen, Inc. Pharmacogenomics (PGx) Product Specification
 3.12.3 Qiagen, Inc. Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.13 Thermo Fisher Scientific
 3.13.1 Thermo Fisher Scientific Company Profile
 3.13.2 Thermo Fisher Scientific Pharmacogenomics (PGx) Product Specification
 3.13.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.14 Rocheg
 3.14.1 Rocheg Company Profile
 3.14.2 Rocheg Pharmacogenomics (PGx) Product Specification
 3.14.3 Rocheg Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.15 Teva Pharmaceutical Industries Ltd.
 3.15.1 Teva Pharmaceutical Industries Ltd. Company Profile
 3.15.2 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product Specification
 3.15.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 4 Global Pharmacogenomics (PGx) Market Competition by Market Players
 4.1 Global Pharmacogenomics (PGx) Production Capacity Market Share by Market Players (2016-2021)
 4.2 Global Pharmacogenomics (PGx) Revenue Market Share by Market Players (2016-2021)
 4.3 Global Pharmacogenomics (PGx) Average Price by Market Players (2016-2021)
 5 Global Pharmacogenomics (PGx) Production by Regions (2016-2021)
 5.1 North America
 5.1.1 North America Pharmacogenomics (PGx) Market Size (2016-2021)
 5.1.2 Pharmacogenomics (PGx) Key Players in North America (2016-2021)
 5.1.3 North America Pharmacogenomics (PGx) Market Size by Type (2016-2021)
 5.1.4 North America Pharmacogenomics (PGx) Market Size by Application (2016-2021)
 5.2 East Asia
 5.2.1 East Asia Pharmacogenomics (PGx) Market Size (2016-2021)
 5.2.2 Pharmacogenomics (PGx) Key Players in East Asia (2016-2021)
 5.2.3 East Asia Pharmacogenomics (PGx) Market Size by Type (2016-2021)
 5.2.4 East Asia Pharmacogenomics (PGx) Market Size by Application (2016-2021)
 5.3 Europe
 5.3.1 Europe Pharmacogenomics (PGx) Market Size (2016-2021)
 5.3.2 Pharmacogenomics (PGx) Key Players in Europe (2016-2021)
 5.3.3 Europe Pharmacogenomics (PGx) Market Size by Type (2016-2021)
 5.3.4 Europe Pharmacogenomics (PGx) Market Size by Application (2016-2021)
 5.4 South Asia
 5.4.1 South Asia Pharmacogenomics (PGx) Market Size (2016-2021)
 5.4.2 Pharmacogenomics (PGx) Key Players in South Asia (2016-2021)
 5.4.3 South Asia Pharmacogenomics (PGx) Market Size by Type (2016-2021)
 5.4.4 South Asia Pharmacogenomics (PGx) Market Size by Application (2016-2021)
 5.5 Southeast Asia
 5.5.1 Southeast Asia Pharmacogenomics (PGx) Market Size (2016-2021)
 5.5.2 Pharmacogenomics (PGx) Key Players in Southeast Asia (2016-2021)
 5.5.3 Southeast Asia Pharmacogenomics (PGx) Market Size by Type (2016-2021)
 5.5.4 Southeast Asia Pharmacogenomics (PGx) Market Size by Application (2016-2021)
 5.6 Middle East
 5.6.1 Middle East Pharmacogenomics (PGx) Market Size (2016-2021)
 5.6.2 Pharmacogenomics (PGx) Key Players in Middle East (2016-2021)
 5.6.3 Middle East Pharmacogenomics (PGx) Market Size by Type (2016-2021)
 5.6.4 Middle East Pharmacogenomics (PGx) Market Size by Application (2016-2021)
 5.7 Africa
 5.7.1 Africa Pharmacogenomics (PGx) Market Size (2016-2021)
 5.7.2 Pharmacogenomics (PGx) Key Players in Africa (2016-2021)
 5.7.3 Africa Pharmacogenomics (PGx) Market Size by Type (2016-2021)
 5.7.4 Africa Pharmacogenomics (PGx) Market Size by Application (2016-2021)
 5.8 Oceania
 5.8.1 Oceania Pharmacogenomics (PGx) Market Size (2016-2021)
 5.8.2 Pharmacogenomics (PGx) Key Players in Oceania (2016-2021)
 5.8.3 Oceania Pharmacogenomics (PGx) Market Size by Type (2016-2021)
 5.8.4 Oceania Pharmacogenomics (PGx) Market Size by Application (2016-2021)
 5.9 South America
 5.9.1 South America Pharmacogenomics (PGx) Market Size (2016-2021)
 5.9.2 Pharmacogenomics (PGx) Key Players in South America (2016-2021)
 5.9.3 South America Pharmacogenomics (PGx) Market Size by Type (2016-2021)
 5.9.4 South America Pharmacogenomics (PGx) Market Size by Application (2016-2021)
 5.10 Rest of the World
 5.10.1 Rest of the World Pharmacogenomics (PGx) Market Size (2016-2021)
 5.10.2 Pharmacogenomics (PGx) Key Players in Rest of the World (2016-2021)
 5.10.3 Rest of the World Pharmacogenomics (PGx) Market Size by Type (2016-2021)
 5.10.4 Rest of the World Pharmacogenomics (PGx) Market Size by Application (2016-2021)
 6 Global Pharmacogenomics (PGx) Consumption by Region (2016-2021)
 6.1 North America
 6.1.1 North America Pharmacogenomics (PGx) Consumption by Countries
 6.1.2 United States
 6.1.3 Canada
 6.1.4 Mexico
 6.2 East Asia
 6.2.1 East Asia Pharmacogenomics (PGx) Consumption by Countries
 6.2.2 China
 6.2.3 Japan
 6.2.4 South Korea
 6.3 Europe
 6.3.1 Europe Pharmacogenomics (PGx) Consumption by Countries
 6.3.2 Germany
 6.3.3 United Kingdom
 6.3.4 France
 6.3.5 Italy
 6.3.6 Russia
 6.3.7 Spain
 6.3.8 Netherlands
 6.3.9 Switzerland
 6.3.10 Poland
 6.4 South Asia
 6.4.1 South Asia Pharmacogenomics (PGx) Consumption by Countries
 6.4.2 India
 6.5 Southeast Asia
 6.5.1 Southeast Asia Pharmacogenomics (PGx) Consumption by Countries
 6.5.2 Indonesia
 6.5.3 Thailand
 6.5.4 Singapore
 6.5.5 Malaysia
 6.5.6 Philippines
 6.6 Middle East
 6.6.1 Middle East Pharmacogenomics (PGx) Consumption by Countries
 6.6.2 Turkey
 6.6.3 Saudi Arabia
 6.6.4 Iran
 6.6.5 United Arab Emirates
 6.7 Africa
 6.7.1 Africa Pharmacogenomics (PGx) Consumption by Countries
 6.7.2 Nigeria
 6.7.3 South Africa
 6.8 Oceania
 6.8.1 Oceania Pharmacogenomics (PGx) Consumption by Countries
 6.8.2 Australia
 6.9 South America
 6.9.1 South America Pharmacogenomics (PGx) Consumption by Countries
 6.9.2 Brazil
 6.9.3 Argentina
 6.10 Rest of the World
 6.10.1 Rest of the World Pharmacogenomics (PGx) Consumption by Countries
 7 Global Pharmacogenomics (PGx) Production Forecast by Regions (2022-2027)
 7.1 Global Forecasted Production of Pharmacogenomics (PGx) (2022-2027)
 7.2 Global Forecasted Revenue of Pharmacogenomics (PGx) (2022-2027)
 7.3 Global Forecasted Price of Pharmacogenomics (PGx) (2022-2027)
 7.4 Global Forecasted Production of Pharmacogenomics (PGx) by Region (2022-2027)
 7.4.1 North America Pharmacogenomics (PGx) Production, Revenue Forecast (2022-2027)
 7.4.2 East Asia Pharmacogenomics (PGx) Production, Revenue Forecast (2022-2027)
 7.4.3 Europe Pharmacogenomics (PGx) Production, Revenue Forecast (2022-2027)
 7.4.4 South Asia Pharmacogenomics (PGx) Production, Revenue Forecast (2022-2027)
 7.4.5 Southeast Asia Pharmacogenomics (PGx) Production, Revenue Forecast (2022-2027)
 7.4.6 Middle East Pharmacogenomics (PGx) Production, Revenue Forecast (2022-2027)
 7.4.7 Africa Pharmacogenomics (PGx) Production, Revenue Forecast (2022-2027)
 7.4.8 Oceania Pharmacogenomics (PGx) Production, Revenue Forecast (2022-2027)
 7.4.9 South America Pharmacogenomics (PGx) Production, Revenue Forecast (2022-2027)
 7.4.10 Rest of the World Pharmacogenomics (PGx) Production, Revenue Forecast (2022-2027)
 7.5 Forecast by Type and by Application (2022-2027)
 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
 7.5.2 Global Forecasted Consumption of Pharmacogenomics (PGx) by Application (2022-2027)
 8 Global Pharmacogenomics (PGx) Consumption Forecast by Regions (2022-2027)
 8.1 North America Forecasted Consumption of Pharmacogenomics (PGx) by Country
 8.2 East Asia Market Forecasted Consumption of Pharmacogenomics (PGx) by Country
 8.3 Europe Market Forecasted Consumption of Pharmacogenomics (PGx) by Countriy
 8.4 South Asia Forecasted Consumption of Pharmacogenomics (PGx) by Country
 8.5 Southeast Asia Forecasted Consumption of Pharmacogenomics (PGx) by Country
 8.6 Middle East Forecasted Consumption of Pharmacogenomics (PGx) by Country
 8.7 Africa Forecasted Consumption of Pharmacogenomics (PGx) by Country
 8.8 Oceania Forecasted Consumption of Pharmacogenomics (PGx) by Country
 8.9 South America Forecasted Consumption of Pharmacogenomics (PGx) by Country
 8.10 Rest of the world Forecasted Consumption of Pharmacogenomics (PGx) by Country
 9 Global Pharmacogenomics (PGx) Sales by Type (2016-2027)
 9.1 Global Pharmacogenomics (PGx) Historic Market Size by Type (2016-2021)
 9.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Type (2022-2027)
 10 Global Pharmacogenomics (PGx) Consumption by Application (2016-2027)
 10.1 Global Pharmacogenomics (PGx) Historic Market Size by Application (2016-2021)
 10.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Application (2022-2027)
 11 Global Pharmacogenomics (PGx) Manufacturing Cost Analysis
 11.1 Pharmacogenomics (PGx) Key Raw Materials Analysis
 11.1.1 Key Raw Materials
 11.2 Proportion of Manufacturing Cost Structure
 11.3 Manufacturing Process Analysis of Pharmacogenomics (PGx)
 12 Global Pharmacogenomics (PGx) Marketing Channel, Distributors, Customers and Supply Chain
 12.1 Marketing Channel
 12.2 Pharmacogenomics (PGx) Distributors List
 12.3 Pharmacogenomics (PGx) Customers
 12.4 Pharmacogenomics (PGx) Supply Chain Analysis
 13 Analyst's Viewpoints/Conclusions
 14 Disclaimer

Add to Cart

Single User

$ 2450.00

Site License

$ 3675.00

Enterprisewide

$ 4900.00